NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index.
The underlying index is composed of common stocks of 30U. S. pharmaceutical companies.
These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 5.13% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 4.97% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 4.96% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.93% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 4.87% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.87% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.80% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 4.69% |
| BHC | Bausch Health Companies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.90% |
| OCUL | Ocular Therapeutix Inc | Healthcare | Biotechnology | 3.73% |
| TARO | Taro Pharmaceutical Industries Ltd | Healthcare | Drug Manufacturers - Specialty & Generic | 3.59% |
| AVDL | Avadel Pharmaceuticals PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.39% |
| LQDA | Liquidia Technologies Inc | Healthcare | Biotechnology | 3.23% |
| HRMY | Harmony Biosciences Holdings | Healthcare | Biotechnology | 3.12% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 3.03% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 3.00% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.00% |
| PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 2.97% |
| PBH | Prestige Brand Holdings Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.95% |
| COLL | Collegium Pharmaceutical Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.92% |